IP Verse
Top Law Firms
Unified Patent Court
Trending Technologies
Blogs
Contact Us
Toggle menu
Kandy Therapeutics Limited opposition analysis
COMPANY ANALYSIS
Latest patents of Kandy Therapeutics Limited opposed by its competitors
Patent:
EP3574907
Grant Date:
Aug 23, 2023
Title:
An Nk-1/Nk-3 Receptor Antagonist For The Treatment Of Sex-Hormone-Dependent Diseases
Oppositions:
1
Latest patents of Kandy Therapeutics Limited opposed by its competitors
Patent Number
Grant Date
Title
Total Oppositions
EP3574907
Aug 23, 2023
An Nk-1/Nk-3 Receptor Antagonist For The Treatment Of Sex-Hormone-Dependent Diseases
1
Competitors of Kandy Therapeutics Limited
AERA A/S
Want to track Kandy Therapeutics Limited?
Feel free to send us a message here and we will get back to you
Name
Email
Message
Let's get in touch